EarningsQ4 2024 Earnings Report

BeOne Medicines (ONCN) Q4 2024 Earnings Report

0 Followers

MX:ONCN Q4 2024 EPS Results

Actual EPS-$25.69

Consensus EPS-$18.18

Beat/MissMissed by -$7.51

One Year Ago EPS-$63.41

Actual Revenue$20.19B

Expected Revenue$18.77B

Beat/MissBeat by +$1.42B

YoY Revenue Growth+75.90%

QuarterQ4 2024

Date02/27/2025

TimeBefore Open

Conference CallThursday, February 27, 2025

MX:ONCN Upcoming Earnings

BeOne Medicines's next earnings date is estimated for October 31, 2026, based on past reporting schedules.

MX:ONCN Q4 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 31, 2026	2026 (Q3)	33.77 / -	19.579	―
Aug 05, 2026	2026 (Q2)	29.84 / 36.82	16.346	125.27% (+20.48)
May 06, 2026	2026 (Q1)	17.39 / 35.21	0	―
Feb 26, 2026	2025 (Q4)	22.35 / 10.78	-25.686	141.96% (+36.46)
Nov 06, 2025	2025 (Q3)	15.29 / 19.58	-20.657	194.78% (+40.24)
Aug 06, 2025	2025 (Q2)	6.95 / 16.35	-20.657	179.13% (+37.00)
May 07, 2025	2025 (Q1)	-10.31 / 0.00	-43.289	―
Feb 27, 2025	2024 (Q4)	-18.18 / -25.69	-63.407	59.49% (+37.72)
Nov 12, 2024	2024 (Q3)	-20.01 / -20.66	36.104	-157.21% (-56.76)
Aug 26, 2024	2024 (Q2)	-39.32 / -20.66	-65.383	68.41% (+44.73)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed